Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Clinical trial NCT04847921 · TERMINATED

Trial details

NCT number: NCT04847921
Sponsor: University of Colorado, Denver
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections Gram-Positive Bacteraemia Substance Use Disorders Intravenous Substance Abuse

Start date: 2021-04-30
Primary completion: 2023-10-05
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.